This article summarized the latest R&D progress of Oxiconazole Nitrate, the Mechanism of Action for Oxiconazole Nitrate, and the drug target R&D trends for Oxiconazole Nitrate.

Acetylcholinesterase (AChE), the primary cholinesterase in the body, is an enzyme catalyzing the breakdown of acetylcholine and of some other choline esters that function as neurotransmitters.

Cue Biopharma shares encouraging results from Phase 1 studies for CUE-101 for Head and Neck Cancer, and CUE-102 for Wilms' Tumor 1 related cases, at the SITC 2023 event.

A Polyclonal antibody (PAb) is a mixture of antibodies produced by different B cells in the body against the same antigen.

At the 38th Society for Immunotherapy of Cancer Meeting, Adagene Inc. presented new data on its anti-CTLA-4 SAFEbody ADG126, revolutionizing new antibody-related therapies.

This article summarized the latest R&D progress of Paroxetine Mesylate, mechanism of action for Paroxetine Mesylate, and the drug target R&D trends for Paroxetine Mesylate.

ACE inhibitors are a class of drugs that work by relaxing blood vessels, inhibiting the production of the vasoconstrictor substance Angiotensin II. This results in lower blood pressure, reduced cardiac load, and decreased risk of hypertension.

A Contrast agent, also known as a contrast medium, is a specific substance that is introduced into the human body for the purpose of medical imaging – it is used to alter the contrast of images of parts of the body.

Kodiak Sciences recently revealed that its Phase III GLOW study of tarcocimab tedromer, a 5 mg ABC therapy for moderate to severe NPDR, met its primary one-year endpoint.

This article summarized the latest R&D progress of Pegvisomant, the Mechanism of Action for Pegvisomant, and the drug target R&D trends for Pegvisomant.

4-1BB (also known as CD137 or TNFRSF9) was first discovered in 1989 and is a critical co-stimulation receptor on T cells and other immune cells.

This article summarized the latest R&D progress of Penicillin G Procaine, the Mechanism of Action for Penicillin G Procaine, and the drug target R&D trends for Penicillin G Procaine.